• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡一家 tertiary 眼科医院的手术性滤过泡修复的结果。

Outcomes of surgical bleb revision at a tertiary Singapore eye hospital.

机构信息

Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore, 168751, Singapore.

Singapore Eye Research Institute, Singapore, Singapore.

出版信息

Int Ophthalmol. 2022 Feb;42(2):443-453. doi: 10.1007/s10792-021-02061-z. Epub 2021 Dec 3.

DOI:10.1007/s10792-021-02061-z
PMID:34860327
Abstract

PURPOSE

To describe the outcomes of surgical bleb revisions from a tertiary glaucoma service in Singapore.

METHODS

One hundred and thirty-one eyes of 129 patients who underwent surgical bleb revisions at the Singapore National Eye Centre between 2007 and 2014 were included in the study. The indications for bleb revision were: bleb-related infection (BRI), early and late bleb leak, early and late overfiltration, and bleb dysesthesia. Regression analysis was applied to elucidate risk factors.

RESULTS

The mean age of the patients was 66 years, 62.6% were male, and 88.5% were Chinese. The majority of the eyes had primary glaucoma (79.4%). The mean interval from the initial trabeculectomy or phaco-trabeculectomy to the bleb revision was 58.8 months. The overall success rate was 69.5%. By Kaplan-Meier survival analysis, the overall cumulative success range fell from 78.6% to 49.1% over 10 years. Eyes with early bleb leak had lower surgical success compared to eyes with late bleb leak, early overfiltration and late overfiltration (P = 0.026, log-rank test). The IOP improved significantly post-operatively for eyes with BRI, early bleb leak, late bleb leak, early overfiltration and overfiltration (P < 0.05). Vision improved significantly in eyes with early overfiltration, but deteriorated in eyes with BRI (P < 0.05).

CONCLUSION

The overall success rate for surgical bleb revisions was good with complete resolution of the primary problem in the majority of cases. However, eyes with early bleb leak were less likely to have successful outcomes and should be monitored more closely post-operatively.

摘要

目的

描述新加坡一家三级青光眼服务中心行手术滤过泡修复术的结果。

方法

本研究纳入了 2007 年至 2014 年间在新加坡国家眼科中心行手术滤过泡修复术的 129 例 131 只眼。行滤过泡修复术的指征包括:滤过泡相关性感染(BRI)、早期和晚期滤过泡渗漏、早期和晚期滤过泡过度引流,以及滤过泡感觉异常。回归分析用于阐明危险因素。

结果

患者的平均年龄为 66 岁,62.6%为男性,88.5%为华人。大多数患者患有原发性青光眼(79.4%)。从初次小梁切除术或超声乳化白内障吸除术到滤过泡修复术的平均间隔时间为 58.8 个月。总体成功率为 69.5%。通过 Kaplan-Meier 生存分析,在 10 年内,总体累积成功率从 78.6%降至 49.1%。与晚期滤过泡渗漏、早期过度引流和晚期过度引流相比,早期滤过泡渗漏的眼手术成功率较低(P=0.026,log-rank 检验)。BRI、早期滤过泡渗漏、晚期滤过泡渗漏、早期过度引流和过度引流的眼术后眼压均显著降低(P<0.05)。早期过度引流的眼视力显著提高,但 BRI 的眼视力恶化(P<0.05)。

结论

手术滤过泡修复术的总体成功率较高,大多数情况下可完全解决主要问题。然而,早期滤过泡渗漏的眼术后结果不太可能成功,应更密切地监测。

相似文献

1
Outcomes of surgical bleb revision at a tertiary Singapore eye hospital.新加坡一家 tertiary 眼科医院的手术性滤过泡修复的结果。
Int Ophthalmol. 2022 Feb;42(2):443-453. doi: 10.1007/s10792-021-02061-z. Epub 2021 Dec 3.
2
Conjunctival advancement versus nonincisional treatment for late-onset glaucoma filtering bleb leaks.结膜推进术与非切开治疗迟发性青光眼滤过泡渗漏的比较
Ophthalmology. 2002 Jan;109(1):71-5. doi: 10.1016/s0161-6420(01)00838-7.
3
Outcomes of surgical bleb revision for complications of trabeculectomy.小梁切除术并发症的手术性滤过泡修复的结果
Ophthalmology. 2009 Sep;116(9):1713-8. doi: 10.1016/j.ophtha.2009.04.003. Epub 2009 Jul 29.
4
Algorithm approach for revision surgery following late-onset bleb complications after trabeculectomy: long-term follow-up.小梁切除术后迟发性滤泡并发症翻修手术的算法方法:长期随访
Arq Bras Oftalmol. 2017 Jan-Feb;80(1):25-29. doi: 10.5935/0004-2749.20170008.
5
Outcomes of surgical bleb revision for late-onset bleb leaks after trabeculectomy.滤过泡修补术治疗小梁切除术后迟发性滤过泡渗漏的疗效。
J Glaucoma. 2013 Jan;22(1):21-5. doi: 10.1097/IJG.0b013e31821e83e6.
6
Outcomes of bleb excision and conjunctival advancement for leaking or hypotonous eyes after glaucoma filtering surgery.青光眼滤过术后渗漏或低眼压性眼行滤泡切除术和结膜徙前术的疗效
Br J Ophthalmol. 2004 Jan;88(1):99-103. doi: 10.1136/bjo.88.1.99.
7
Surgical repair of leaking filtering blebs.渗漏性滤过泡的手术修复
Ophthalmology. 2000 Sep;107(9):1681-7. doi: 10.1016/s0161-6420(00)00282-7.
8
Revision of dysfunctional filtering blebs by conjunctival advancement with bleb preservation.通过结膜推进联合保留滤过泡修复功能失调的滤过泡
Am J Ophthalmol. 2000 Nov;130(5):574-9. doi: 10.1016/s0002-9394(00)00653-x.
9
Free conjunctival autologous graft for bleb repair and bleb reduction after trabeculectomy and nonpenetrating filtering surgery.小梁切除术和非穿透性滤过手术后用于修复滤过泡和减少滤过泡的游离结膜自体移植术。
J Glaucoma. 2002 Feb;11(1):10-6. doi: 10.1097/00061198-200202000-00003.
10
Long-term follow up of surgical repair of late bleb leaks after glaucoma filtering surgery.青光眼滤过术后晚期滤泡渗漏手术修复的长期随访
J Glaucoma. 2006 Oct;15(5):432-6. doi: 10.1097/01.ijg.0000212257.02702.e8.

引用本文的文献

1
Efficacy and safety of combined Kahook Dual Blade goniotomy with phacoemulsification in Chinese patients with primary open angle glaucoma.卡胡克双刃房角切开术联合白内障超声乳化术治疗中国原发性开角型青光眼患者的疗效与安全性
Int J Ophthalmol. 2025 Feb 18;18(2):268-274. doi: 10.18240/ijo.2025.02.10. eCollection 2025.
2
Three-year outcomes of surgical bleb revision with mitomycin C for early scarring bleb after trabeculectomy.小梁切除术后早期瘢痕性滤过泡行丝裂霉素C手术性滤过泡修复的三年随访结果
Jpn J Ophthalmol. 2025 Jan;69(1):101-109. doi: 10.1007/s10384-024-01142-7. Epub 2024 Nov 21.
3
Safety and Efficacy of the Rho-Kinase Inhibitor (Ripasudil) in Bleb Needling after Trabeculectomy: A Prospective Multicenter Study.

本文引用的文献

1
A review of trabeculectomy in East Asian people--the influence of race.东亚人群小梁切除术综述——种族的影响
Eye (Lond). 2005 Mar;19(3):243-52. doi: 10.1038/sj.eye.6701477.
2
Trabeculectomy survival with and without intra-operative 5-fluorouracil application in an Asian population.亚洲人群中术中应用与未应用5-氟尿嘧啶的小梁切除术成功率
Aust N Z J Ophthalmol. 1998 Nov;26(4):283-8. doi: 10.1111/j.1442-9071.1998.tb01331.x.
小梁切除术后房水引流泡针刺术中使用Rho激酶抑制剂(ripasudil)的安全性和有效性:一项前瞻性多中心研究。
J Clin Med. 2023 Dec 22;13(1):75. doi: 10.3390/jcm13010075.
4
A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy.一项关于小梁切除术后患者使用Rho激酶抑制剂(ripasudil)联合针刺安全性的多中心II期研究。
Contemp Clin Trials Commun. 2023 Jun 4;33:101160. doi: 10.1016/j.conctc.2023.101160. eCollection 2023 Jun.